News tagged with multiple myeloma
Researchers sequence multiple myeloma genome in landmark study
Using new genome sequencing technologies, researchers from the John Theurer Cancer Center at Hackensack University Medical Center joined colleagues from 20 major North American research institutions to publish the first complete ...
Mar 23, 2011 |
4.7 / 5 (3) |
0
|
Protein helps immune cells to divide and conquer
Researchers at the University of California, San Diego School of Medicine have identified a key protein that is required for immune cells called B lymphocytes to divide and replicate themselves. The rapid generation of large ...
Medicine & Health / Medical research
Mar 08, 2009 |
5 / 5 (1) |
0
Researchers pinpoint how one cancer gene functions
For several decades, researchers have been linking genetic mutations to diseases ranging from cancer to developmental abnormalities. What hasn't been clear, however, is how the body's genome sustains such destructive glitches ...
Feb 02, 2011 |
5 / 5 (2) |
0
|
New use for once-cursed drug Thalidomide?
Thalidomide, the sedative blamed for tragic birth defects half a century ago, treated a rare inherited blood disorder, according to lab experiments reported on Sunday.
Medicine & Health / Medications
Apr 04, 2010 |
5 / 5 (5) |
0
Study identifies key molecules in multiple myeloma
New research links three molecules to a critical tumor suppressor gene that is often turned off in multiple myeloma, a presently incurable cancer of the blood.
Oct 26, 2010 |
5 / 5 (1) |
0
|
Biologists image birth of blood-forming stem cells in embryo (w/ Video)
Biologists at UC San Diego have identified the specific region in vertebrates where adult blood stem cells arise during embryonic development.
Feb 14, 2010 |
5 / 5 (3) |
1
|
Protein offers new clue to cause and treatment for kidney disease
University of Alabama at Birmingham researchers have pinpointed a protein that compromises the kidney's filtering ability, causing nephrotic syndrome, and demonstrated that a naturally occurring precursor of an acid in the ...
Medicine & Health / Medical research
Dec 12, 2010 |
4.3 / 5 (4) |
0
|
Getting down to cancer basics
Researchers have identified a new cancer gene - one that is common to many cancers and affects the most basic regulation of our genes. The new example - a gene on the X chromosome called UTX - is found in 10% of cases of ...
Mar 29, 2009 |
4.3 / 5 (7) |
0
$93,000 cancer drug: How much is a life worth?
Cancer patients, brace yourselves. Many new drug treatments cost nearly $100,000 a year, sparking fresh debate about how much a few months more of life is worth.
Sep 26, 2010 |
5 / 5 (3) |
6
New class of drugs for the reversible inhibition of proteasomes
As the "recycling plant" of the cell, the proteasome regulates vitally important functions. When it is inhibited, the cell chokes on its own waste. Cancer cells, in particular, are very sensitive because they ...
Nov 22, 2011 |
not rated yet |
0
Research first to combine targeted agents to kill multiple myeloma cells
(PhysOrg.com) -- Scientists at Virginia Commonwealth University Massey Cancer Center have developed a novel treatment strategy for multiple myeloma that pairs two targeted agents to kill cancer cells. The study’s findings, ...
Feb 10, 2011 |
not rated yet |
0
Potential new multiple myeloma therapy developed
A treatment for the incurable blood cancer Multiple Myeloma could be developed in the future if a groundbreaking scientific discovery is applied to new Leeds-based research into the disease.
Jan 06, 2011 |
5 / 5 (1) |
0
Less intensive drug schedule as effective as standard treatment for blood cancer
A less intensive bortezomib-based regimen (given once instead of twice per week) followed by maintenance therapy, is as effective as the standard treatment for elderly patients with multiple myeloma, but with fewer serious ...
Aug 23, 2010 |
not rated yet |
0
Scientists discover inner workings of potent cancer drug
A potent drug derived from an evergreen tree may soon save the lives of some patients with the deadliest form of breast cancer. According to the National Cancer Institute, breast cancer will claim approximately ...
Oct 14, 2010 |
not rated yet |
0
Improvement in prediction of blood clots in cancer patients
For cancer patients, who have an increased risk of developing venous thromboembolism (VTE) due to a hyperactive blood coagulation system, there is now an enhanced risk model to predict their chance of developing blood clots, ...
Sep 09, 2010 |
1 / 5 (1) |
0
Multiple myeloma
Multiple myeloma (from myelo-, bone marrow), also known as MM, myeloma, plasma cell myeloma, or as Kahler's disease (after Otto Kahler) is a cancer of the white blood cells known as plasma cells, which produce antibodies.
These plasma cells, or B cells, are part of the immune system, formed in bone marrow, and numerous in lymphatics. Myeloma is incurable, but remissions may be induced with steroids, chemotherapy, thalidomide and stem cell transplants.
There were 15,270 cases diagnosed and 11,070 deaths in the United States in 2004, and an incidence of 4/100,000 worldwide. Median survival is 50–55 months. Chromosome diagnosis can separate patients into more or less favorable prognoses.
Myeloma is part of the broad group of diseases called hematological malignancies.
For more information about Multiple myeloma, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
